HUP9900079A2 - 12H-Dibenzo[d,g][1,3]dioxocin-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények - Google Patents
12H-Dibenzo[d,g][1,3]dioxocin-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP9900079A2 HUP9900079A2 HU9900079A HUP9900079A HUP9900079A2 HU P9900079 A2 HUP9900079 A2 HU P9900079A2 HU 9900079 A HU9900079 A HU 9900079A HU P9900079 A HUP9900079 A HU P9900079A HU P9900079 A2 HUP9900079 A2 HU P9900079A2
- Authority
- HU
- Hungary
- Prior art keywords
- pipe powder
- general formula
- ring
- alkyl
- xviii
- Prior art date
Links
- IXCQKGJMGWEDCH-UHFFFAOYSA-N 5h-benzo[d][1,3]benzodioxocine Chemical class O1COC2=CC=CC=C2CC2=CC=CC=C21 IXCQKGJMGWEDCH-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000843 powder Substances 0.000 abstract 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical class C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 abstract 1
- 208000007920 Neurogenic Inflammation Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000000917 hyperalgesic effect Effects 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000035790 physiological processes and functions Effects 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
A találmány új (I) általánős képletű -, ahől R1 és R2 jelentéseegymástól függetlenül hidrőgénatőm, halőgénatőm, triflűőr-metil-,hidrőxil-, 1-6 szénatőmős alkil- vagy 1-6 szénatőmős alkőxicsőpőrt; R3jelentése hidrőgénatőm vagy 1-3 szénatőmős alkilcsőpőrt; A jelentése1-3 szénatőmős alkilcsőpőrt; Y jelentése >CH-CH2-, >C=CH-, >CH-O-, >C-N- vagy >N-CH2- képletű csőpőrt, ahől csak az aláhúzőtt atőmős vesznekrészt a gyűrűs rendszerben - Z jelentése R14 csőpőrttal és adőttesetben más csőpőrtőkkal helyettesített aziridinő-, pirrőlidinő-,mőrfőlinő-, adőtt esetben benzőlgyűrűvel kőndenzált piperidinőcsőpőrt,vagy részben telített 6-tagú 1N-atőmőt tartalmazó gyűrű vagy (XV),(XVI), (XVII), (XVIII) általánős képletű csőpőrt, R14 jelentése -(CH2)mOH vagy -(CH2)tCOR15 általánős képletű csőpőrt, ahől m=0-6 és t= 0, 1 vegyületekkel, előállítási eljárásőkkal, az említettvegyületeket tartalmazó gyógyszerkészítményekkel és őlyan fájdalmak,hiperalgéziás és/vagy gyűlladásős állapőtők klinikai kezelésébentörténő felhasználásűkkal főglalkőzik, melyeknél a C-idegrőstőkpatőfiziőlógiás szerepet játszanak, neűrőgén fájdalmat vagy gyűlladástkiváltva. (I) (XV) (XVI) (XVII) (XVIII) ŕ
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK104195 | 1995-09-19 | ||
| DK104095 | 1995-09-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9900079A2 true HUP9900079A2 (hu) | 1999-10-28 |
| HUP9900079A3 HUP9900079A3 (en) | 2000-02-28 |
Family
ID=26065121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9900079A HUP9900079A3 (en) | 1995-09-19 | 1996-09-12 | 12h-dibenzo[d,g][1,3]dioxocine derivatives, process for their preparation, their use and pharmaceutical compositions containing the same |
Country Status (22)
| Country | Link |
|---|---|
| US (6) | US5753678A (hu) |
| EP (1) | EP0851865B1 (hu) |
| JP (1) | JP3499569B2 (hu) |
| KR (1) | KR100437561B1 (hu) |
| CN (1) | CN1090629C (hu) |
| AR (1) | AR004513A1 (hu) |
| AT (1) | ATE220674T1 (hu) |
| AU (1) | AU700784B2 (hu) |
| BR (1) | BR9610524A (hu) |
| CA (1) | CA2231835A1 (hu) |
| CZ (1) | CZ70998A3 (hu) |
| DE (1) | DE69622415T2 (hu) |
| ES (1) | ES2179206T3 (hu) |
| HU (1) | HUP9900079A3 (hu) |
| IL (1) | IL123424A (hu) |
| MX (1) | MX9802126A (hu) |
| NO (1) | NO981216L (hu) |
| PL (1) | PL186708B1 (hu) |
| PT (1) | PT851865E (hu) |
| RU (1) | RU2178790C2 (hu) |
| TW (1) | TW406078B (hu) |
| WO (1) | WO1997011071A1 (hu) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5952352A (en) * | 1995-04-07 | 1999-09-14 | Novo Nordisk A/S | Heterocyclic compounds |
| DK0934312T3 (da) * | 1996-10-04 | 2003-07-21 | Novo Nordisk As | 1,4-disubstituerede piperaziner |
| US6040318A (en) * | 1997-06-25 | 2000-03-21 | Novo Nordisk A/S | Tricycle substituted with azaheterocyclic carboxylic acids |
| TW200400816A (en) | 2002-06-26 | 2004-01-16 | Lilly Co Eli | Tricyclic steroid hormone nuclear receptor modulators |
| US7723349B2 (en) | 2003-04-24 | 2010-05-25 | Incyte Corporation | Aza spiro alkane derivatives as inhibitors of metalloproteases |
| WO2007143600A2 (en) * | 2006-06-05 | 2007-12-13 | Incyte Corporation | Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU174126B (hu) * | 1977-08-02 | 1979-11-28 | Egyt Gyogyszervegyeszeti Gyar | Sposob poluchenija novykh proizvodnykh dibenzo-kvadratnaja skobka-d,g-kvadratnaja skobka zakryta-kvadratnaja skobka-1,3,6-kvadratnaja skobka zakryta-dioksazocina |
| HU195491B (en) * | 1985-12-20 | 1988-05-30 | Egyt Gyogyszervegyeszeti Gyar | Process for production of optically active 2-chlor-12-/3-/dimethil-amin/-2-methil-prophil/-12h-dibenzol /d,g/ /1,3,6/-diaxazocine and medical compositions containing such compounds |
| HU201318B (en) * | 1987-12-31 | 1990-10-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing dioxazoline derivatives and pharmaceutical compositions comprising same |
| CN1074926A (zh) * | 1992-01-29 | 1993-08-04 | 大连石油化工公司有机合成厂 | 混合原油破乳剂的制备方法 |
-
1996
- 1996-09-12 WO PCT/DK1996/000382 patent/WO1997011071A1/en not_active Application Discontinuation
- 1996-09-12 AU AU69234/96A patent/AU700784B2/en not_active Ceased
- 1996-09-12 KR KR10-1998-0702036A patent/KR100437561B1/ko not_active IP Right Cessation
- 1996-09-12 AT AT96930027T patent/ATE220674T1/de not_active IP Right Cessation
- 1996-09-12 BR BR9610524A patent/BR9610524A/pt not_active IP Right Cessation
- 1996-09-12 EP EP96930027A patent/EP0851865B1/en not_active Expired - Lifetime
- 1996-09-12 RU RU98107807/04A patent/RU2178790C2/ru not_active IP Right Cessation
- 1996-09-12 HU HU9900079A patent/HUP9900079A3/hu unknown
- 1996-09-12 JP JP51232897A patent/JP3499569B2/ja not_active Expired - Fee Related
- 1996-09-12 CA CA002231835A patent/CA2231835A1/en not_active Abandoned
- 1996-09-12 DE DE69622415T patent/DE69622415T2/de not_active Expired - Fee Related
- 1996-09-12 PT PT96930027T patent/PT851865E/pt unknown
- 1996-09-12 PL PL96325637A patent/PL186708B1/pl not_active IP Right Cessation
- 1996-09-12 IL IL12342496A patent/IL123424A/en not_active IP Right Cessation
- 1996-09-12 CZ CZ98709A patent/CZ70998A3/cs unknown
- 1996-09-12 MX MX9802126A patent/MX9802126A/es not_active IP Right Cessation
- 1996-09-12 CN CN96197078A patent/CN1090629C/zh not_active Expired - Fee Related
- 1996-09-12 ES ES96930027T patent/ES2179206T3/es not_active Expired - Lifetime
- 1996-09-18 US US08/715,665 patent/US5753678A/en not_active Expired - Fee Related
- 1996-09-18 AR ARP960104401A patent/AR004513A1/es unknown
- 1996-09-30 TW TW085111986A patent/TW406078B/zh not_active IP Right Cessation
-
1997
- 1997-09-04 US US08/922,977 patent/US5972925A/en not_active Expired - Fee Related
- 1997-10-24 US US08/957,163 patent/US5912262A/en not_active Expired - Fee Related
- 1997-10-24 US US08/957,172 patent/US5917047A/en not_active Expired - Fee Related
-
1998
- 1998-03-18 NO NO981216A patent/NO981216L/no not_active Application Discontinuation
- 1998-05-15 US US09/079,599 patent/US6017915A/en not_active Expired - Fee Related
- 1998-05-15 US US09/079,935 patent/US5916901A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0303084A2 (hu) | Gyulladásgátló hatású 17béta-karbotioát-17alfa-arilkarboniloxiloxi androsztán-származékok, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
| FI951614A (fi) | D-vitamiinisarjan 25-karboksyylihappojohdannaisia, menetelmät niiden valmistamiseksi, näissä menetelmissä käytettävät välituotteet, näitä johdansia sisältävät farmaseuttiset valmisteet ja näiden johdannaisten käyttö lääkeaineiden valmistukseen | |
| MX9710261A (es) | Compuestos aromaticos y composiciones farmaceuticas que los contienen. | |
| MX9710218A (es) | Compuestos aromaticos y composiciones farmaceuticas que los contienen. | |
| ES8702406A1 (es) | Procedimiento para preparar derivados de imidazo (1,5-a) pi-ridina | |
| HUP9802757A2 (hu) | Új naftalénszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények | |
| ES8404361A1 (es) | Un procedimiento para la preparacion de un derivado de cefalosporina. | |
| HUP9900079A2 (hu) | 12H-Dibenzo[d,g][1,3]dioxocin-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
| DE68917220D1 (de) | Phenylpyridon-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen. | |
| HUP9802492A2 (hu) | Antipszichotikus hatású benzizoxazol- és indazolszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
| IE790630L (en) | 2, 6-dialkoxybenzamido-pyrrolidines. | |
| HUP9701660A2 (hu) | 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények | |
| GB1497985A (en) | Oxazolo-pyridines their preparation and use and compositions containing them | |
| ES8101590A1 (es) | Un procedimiento para la preparacion de pirimido-2-benzace- pinas | |
| HUP9800422A1 (hu) | 2-Amino-indán-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények | |
| ES466192A1 (es) | Procedimiento para la obtencion de derivados de la isoqui- noleina. | |
| AU658175B2 (en) | Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients | |
| NO960425D0 (no) | 15,15-dialkyl-substituerte derivater av östradiol | |
| DE3878967T2 (de) | 17-aza-20,21-dinoreburnameninderivate, verfahren und zwischenprodukte zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen. | |
| ES487631A1 (es) | Procedimiento para la obtencion de hexahidro-1,4-oxazepinas | |
| ES8308317A1 (es) | Procedimiento de preparacion de nuevos derivados de 2-fenilmorfolina. | |
| ES8704951A1 (es) | Un procedimiento para la preparacion de nuevos derivados penem. | |
| IE41575L (en) | 11-(3'-NORTROPYLIDENE)-6,11-DIHYDRODIBENZO[b,e] THIEPINE¹DERIVATIVES | |
| GB1452877A (en) | 2-oxo-1,2,3,4-tetra-hydropyrido-2,3,d-pyrimidines | |
| ATE56440T1 (de) | 6-oxo-pyridazinyl-verbindungen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |